NCT07520032 Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Function Patients With Stroke.
| NCT ID | NCT07520032 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Gulf Medical University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-10-30 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-10-30 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Stroke is a leading cause of death and disability worldwide. A major complication of stroke is spasticity, marked by increased muscle tone and impaired movement. It affects majority stroke patients and complicates rehabilitation, affecting the upper limb function of survivors. While traditional treatments like oral medications and botulinum toxin injections offer some relief, they have notable limitations, causing the need for novel, non-invasive approaches. Extracorporeal shock wave therapy (ESWT), which uses acoustic waves for regeneration and neuromodulation, has shown promise in reducing spasticity with minimal side effects, though its precise mechanisms and ideal protocols need further study. Current evidence supports ESWT's efficacy and safety, often matching established treatments, but gaps remain regarding standardized application and long-term functional outcomes, highlighting the need for more robust research.
Eligibility Criteria
Inclusion criteria: 1. Diagnosed as 1st stroke incidence 6 months back 2. Both male and female 3. Age 25 to 65 years 4. the ability to follow verbal instructions 5. Modified Ashworth Scale score 1-4 Exclusion criteria: 1. Recurrent stroke. 2. Severe contractures or deformities of upper extremity. 3. Chronic pain affecting upper extremity function. 4. malignant tumor, pacemakers, infection
Contact & Investigator
Sharmila banu Ali, DPT/MPT
PRINCIPAL INVESTIGATOR
Thumbay Physical Therapy and Rehabilitation Hospital
Frequently Asked Questions
Who can join the NCT07520032 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07520032 currently recruiting?
Yes, NCT07520032 is actively recruiting participants. Contact the research team at sharmieashak@gmail.com for enrollment information.
Where is the NCT07520032 trial being conducted?
This trial is being conducted at Ajman, United Arab Emirates.
Who is sponsoring the NCT07520032 clinical trial?
NCT07520032 is sponsored by Gulf Medical University. The principal investigator is Sharmila banu Ali, DPT/MPT at Thumbay Physical Therapy and Rehabilitation Hospital. The trial plans to enroll 50 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.